Literature DB >> 2831078

The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in rats.

A M Koelz1, S Bertschin, M Hermle, M Mihatsch, F P Brunner, G Thiel.   

Abstract

The influence of the renin-angiotensin system on renal hemodynamics, tubular pressure and tubulo-glomerular feedback was investigated with the angiotensin converting enzyme inhibitor MK 421 (enalapril), in uninephrectomized rats with and without ischemia-induced acute renal failure. In animals with normal renal function proximal tubular pressure and tubulo-glomerular feedback response were lowered by enalapril long-term treatment, whereas glomerular filtration rate and renal blood flow were not influenced by the drug. After 45 and 70 minutes ischemia there was no difference between treated and untreated animals in the severely impaired glomerular filtration rate. Renal blood flow remained unaffected by the treatment. The histological damage due to ischemia (tubular casts, tubular necrosis and medullary capillary congestion) was not influenced by enalapril. As tubulo-glomerular feedback had been significantly inhibited during renin-angiotensin inhibition, its importance in mediating acute renal failure remains doubtful; other factors such as tubular obstruction and medullary congestion may be crucial.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831078     DOI: 10.1007/BF01952206

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  13 in total

1.  [THE SODIUM CONCENTRATION IN THE MACULA DENSA CELLS AS A REGULATING FACTOR FOR GLOMERULAR FILTRATION (MICROPUNCTURE EXPERIMENTS)].

Authors:  K THURAU; J SCHNERMANN
Journal:  Klin Wochenschr       Date:  1965-04-15

2.  Pathophysiology of a vasomotor and nephrotoxic model of acute renal failure in the dog.

Authors:  J H Stein; M I Sorkin
Journal:  Kidney Int Suppl       Date:  1976-10       Impact factor: 10.545

3.  Feedback regulation of nephron filtration rate during pharmacologic interference with the renin-angiotensin and adrenergic systems in rats.

Authors:  N Stowe; J Schnermann; M Hermle
Journal:  Kidney Int       Date:  1979-05       Impact factor: 10.612

4.  Active and passive immunization to angiotensin in experimental acute renal failure.

Authors:  D E Oken; S C Cotes; W Flamenbaum; J D Powell-Jackson; A F Lever
Journal:  Kidney Int       Date:  1975-01       Impact factor: 10.612

5.  Enhancement of recovery in postischemic acute renal failure with captopril.

Authors:  M O Magnusson; S J Rybka; N T Stowe; A C Novick; R A Straffon
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

6.  Angiotensin II control of the renal microcirculation: effect of blockade by saralasin.

Authors:  M Steinhausen; H Kücherer; N Parekh; S Weis; D L Wiegman; K R Wilhelm
Journal:  Kidney Int       Date:  1986-07       Impact factor: 10.612

7.  Selective inhibition of thromboxane synthesis partially protected while inhibition of angiotensin II formation did not protect rats against acute renal failure induced with glycerol.

Authors:  N Papanicolaou; C Hatziantoniou; J Bariety
Journal:  Prostaglandins Leukot Med       Date:  1986-01

8.  Angiotensin II immunoreactivity coexists with renin in the juxtaglomerular granular cells of the kidney.

Authors:  M R Celio; T Inagami
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

9.  [Experimental studies on the modifiability of ischemic acute renal failure by saralasin].

Authors:  H H Schuldt; H Oesterwitz
Journal:  Z Urol Nephrol       Date:  1985-11

Review 10.  Glomerular actions of angiotensin II.

Authors:  I Ichikawa; B M Brenner
Journal:  Am J Med       Date:  1984-05-31       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.